MedPath

Comparison of Ultrasound-Guided Median nerve Hydrodissection with Corticosteroid Injection in the treatment of mild to moderate Carpal Tunnel Syndrome

Not Applicable
Recruiting
Conditions
Carpal tunnel syndrome.
Carpal tunnel syndrome
G56.0
Registration Number
IRCT20210613051566N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Confirmed clinical and Electrophysiological diagnosis of Carpal Tunnel Syndrome with mild to moderate degree

Exclusion Criteria

Confirmed clinical and Electrophysiological diagnosis of CTS with severe degree
Patients with suspicious of CTS mimic condition, including cervical radiculopathy, polyneuropathy, brachial plexopathy, thoracic outlet syndrome
Recent corticosteroid injection to the carpal tunnel within 6 months
Previous history of carpal tunnel surgical release
Steroid injection contraindications
Pregnancy
Cancer
Coagulopathy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Boston carpal tunnel syndrome questionnaire (BCTQ). Timepoint: Pre-treatment, 1st, 3rd and 6th months after injection. Method of measurement: five-point rating scale questionnaire.
Secondary Outcome Measures
NameTimeMethod
Visual Analog Scale (VAS) for Pain. Timepoint: Pre injection, 2 weeks, 1, 3 and 6 months intervals. Method of measurement: Visual and numeric scale.;Cross-sectional area of the Median nerve. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: Ultrasound device.;Conduction Velocity, Distal Latency and Amplitude of Median nerve SNAP & CMAP. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: EMG- NCV.;Hand grip strength. Timepoint: Pre injection, 1, 3 and 6 months intervals. Method of measurement: Dynamometer.
© Copyright 2025. All Rights Reserved by MedPath